Destaques
O foco nas pesquisas sobre COVID-19 ameniza e o número de publicações começa a estabilizar – pesquisadores que saíram de disciplinas distantes e mudaram seu campo de pesquisa publicaram trabalhos de menor impacto.
30 Mai, 2022 | 13:18hPivot into COVID-19 research eases as publishing surge starts to level off – Science
Insuficiência ventricular direita está fortemente associada com mortalidade em pacientes com síndrome da angústia respiratória aguda (SARA) relacionada a COVID-19 moderada a grave.
30 Mai, 2022 | 13:17h
Comentário no Twitter
RV failure in moderate-to-severe #COVID19 #ARDS
➡️strong predictor of mortality
➡️significant worsening of PaO2/FiO2, PaCO2 & ventilatory ratio (⬆️ pulm vasoconstriction) & ⬆️ driving P could contribute#POCUS mandatory especially if resp deterioration.
📎 https://t.co/OE56BuxeWz pic.twitter.com/dNIeo1yHcP— Intensive Care Medicine (@yourICM) May 16, 2022
Estimativas do impacto global, regional e nacional das infecções agudas de trato respiratório inferior causadas por vírus sincicial respiratório em crianças com menos de 5 anos de idade em 2019.
30 Mai, 2022 | 13:16hComentários:
Need for improved global measurement of early childhood respiratory syncytial virus disease – The Lancet (necessário cadastro gratuito)
RSV kills 100,000 kids under age 5 a year worldwide – CHEST Physician
Ampla avaliação das políticas para COVID-19 e desfechos em 50 países e territórios.
30 Mai, 2022 | 13:14hCovid-19: estudo mostra que a efetividade vacinal diminui mais rapidamente em pacientes oncológicos.
30 Mai, 2022 | 13:13hComentário: Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study finds – The BMJ
Principais estudos de 2021 relevantes para a atenção primária.
27 Mai, 2022 | 13:47hTop studies of 2021 relevant to primary care: From the PEER team – Canadian Family Physician
Estudo relata primeiro uso de antivirais em pacientes com varíola dos macacos.
27 Mai, 2022 | 13:45hComunicado de imprensa: Study reports first use of antivirals in monkeypox patients – Lancet
Estudo original: Clinical features and management of human monkeypox: a retrospective observational study in the UK – The Lancet Infectious Diseases
Comentário: Antiviral drug may limit monkeypox symptom duration, infectiousness – CIDRAP
Comentário de um dos autores no Twitter (fio – clique para saber mais)
Clinical features and management of human monkeypox: a retrospective observational study in the UK https://t.co/0nUtw3lEDn
— Jake Dunning (@OutbreakJake) May 24, 2022
Comentário de estudo | Grande estudo mostra que risco de COVID longa diminui apenas discretamente após a vacinação.
27 Mai, 2022 | 13:44hComentário: Long COVID risk falls only slightly after vaccination, huge study shows – Nature
Estudo original: Long COVID after breakthrough SARS-CoV-2 infection – Nature Medicine
Comentário do autor no Twitter (fio – clique para saber mais)
The latest from our team in @NatureMedicine
Does vaccination protect from #LongCovid?
Vaccines modestly reduce but do not eliminate risk of Long Covid @VAResearch @vahsrd @WUSTLmed @WUSTLnews @VREFSTL@Biostayan @BCBowe https://t.co/UEexmL8svS
A thread 🧵
— Ziyad Al-Aly, MD (@zalaly) May 25, 2022
Estudo de coorte | Trajetória dos sintomas de Covid longa após vacinação contra Covid-19.
27 Mai, 2022 | 13:41hTrajectory of long covid symptoms after covid-19 vaccination: community based cohort study – The BMJ
Editorial: Are vaccines a potential treatment for long covid? – The BMJ
Comunicado de imprensa: Vaccination after SARS-CoV-2 infection linked to a decrease in long covid symptoms – BMJ Newsroom
Comentário no Twitter
LONG COVID: Number of well controlled studies (controls means comparison group of 1) unvaccinated and 2) those who have never had COVID) that show vaccination works to reduce or eliminate long COVID symptoms increasing. BMJ below + biggest from Israel herehttps://t.co/jtZ6aoDmFA https://t.co/n5oDs0Zxe9
— Monica Gandhi MD, MPH (@MonicaGandhi9) May 19, 2022
Estudo de coorte | Proteção e queda da imunidade natural e híbrida ao SARS-CoV-2.
27 Mai, 2022 | 13:39hProtection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 – New England Journal of Medicine
Editorial: Audio Interview: Waning Immunity against Covid-19
Comentário no Twitter
Protection against SARS-CoV-2 waned over time in both vaccinated and previously infected persons; an additional vaccine dose restored protection, find investigators from Israel. https://t.co/617uBmWu8l pic.twitter.com/yiDnBbCuQ5
— NEJM (@NEJM) May 25, 2022